TAKEDA PHARMACEUTICAL CO LTD Historic Quarter Change: USA Stocks, Reduced

TAKEDA PHARMACEUTICAL CO LTD historic quarter change: USA Stocks, Reduced

In share positions in stocks (listed in the US), over 7 quarters from 2023-12-31 to 2025-09-30, TAKEDA PHARMACEUTICAL CO LTD opened 3 positions, added to 0, reduced 7 and sold out of 6.

Q3 2024: Stock RANI; Country of operation United States; Class COM CL A; Shares before 215,172.
Q3 2024: Stock AMWL; Country of operation United States; Class COM CL A NEW; Shares before 1,554,669.
Q2 2024: Stock PHAT; Country of operation United States; Class COM; Shares before 3,153,217.
Q2 2024: Stock STTK; Country of operation United States; Class COM; Shares before 1,501,061.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1395064), 7 quarters: Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-13); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-08); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-12); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-12); Q3 2024 (2024-06-30 to 2024-09-30, filed 2025-02-13); Q2 2024 (2024-03-31 to 2024-06-30, filed 2025-02-13); Q1 2024 (2023-12-31 to 2024-03-31, filed 2025-02-13). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2024-12-31.

Quarter	Stock	Country of operation	Class	Shares before	Shares after	Share change	Value before	Value after	Value change	Filed
Q3 2024	RANI Rani Therapeutics Holdings, Inc.	United States	COM CL A	215,172	203,190	-11,982	$817,654	$438,890	-$378,764	2025-02-13
Q3 2024	AMWL American Well Corp	United States	COM CL A NEW	1,554,669	77,733	-1,476,936	$505,267	$736,913	+$231,646	2025-02-13
Q2 2024	PHAT Phathom Pharmaceuticals, Inc.	United States	COM	3,153,217	1,557,063	-1,596,154	$33,487,165	$16,037,749	-$17,449,416	2025-02-13
Q2 2024	STTK Shattuck Labs, Inc.	United States	COM	1,501,061	515,619	-985,442	$13,419,185	$1,990,289	-$11,428,896	2025-02-13
Q2 2024	RANI Rani Therapeutics Holdings, Inc.	United States	COM CL A	338,679	215,172	-123,507	$1,053,292	$817,654	-$235,638	2025-02-13
Q1 2024	PHAT Phathom Pharmaceuticals, Inc.	United States	COM	7,459,286	3,153,217	-4,306,069	$77,352,796	$33,487,165	-$43,865,631	2025-02-13
Q1 2024	STTK Shattuck Labs, Inc.	United States	COM	2,090,858	1,501,061	-589,797	$14,907,818	$13,419,185	-$1,488,633	2025-02-13

Similar Firms

Firm Name	Country	13F Value	Holdings
Not available yet